US equities |
SPCX $167.05 ▲+5.09% NVDA $237.06 ▲+1.33% MU $1,066.45 ▼-0.79% TSLA $375.38 ▲+1.29% MSFT $526.22 ▲+1.68% INTC $117.06 ▼-1.90% SNDK $1,720.95 ▲+0.06% META $743.14 ▲+2.07%
FinancialContent

22nd Century Group, Inc - Common Stock (NQ:XXII)

0.9201 +0.0061 (+0.67%)
Delayed Quote Updated: 10:47 AM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about 22nd Century Group, Inc - Common Stock

< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
25 26 Next >
News headline image
22nd Century Group (XXII) Q4 2022 Earnings Call Transcript ↗
XXII earnings call for the period ending December 31, 2022. 
Via The Motley Fool
News headline image
22nd Century Group Q4 2022 Net Revenue Grows 141.3% YoY, What About Profit? ↗
22nd Century Group, Inc. (NASDAQ: XXII) net revenue for the Q4 2022 was $19.2 million, an increase of 141.3% from $8 million in Q4 2021. Q4 2022 Financial Highlights 
Via Benzinga
News headline image
22nd Century Group (Nasdaq: XXII) Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
From 22nd Century Group, Inc
Via GlobeNewswire
News headline image
Marijuana Stock Movers For March 8, 2023 ↗
 
Via Benzinga
News headline image
22nd Century Group Secures $21M Debt Financing For Accelerated Expansion ↗
22nd Century Group, Inc. 
Via Benzinga
Marijuana Stock Movers For January 24, 2023 ↗
 
Via Benzinga
News headline image
Cannabis Stock Movers For March 3, 2023 ↗
 
Via Benzinga
News headline image
22nd Century Group (XXII) Secures $21 Million Debt Financing to Expand Working Capital for Growth Initiatives
Supports Accelerated Expansion of VLN Multi-State Retail Channels, GVB Global Ingredients and CDMO Business 
From 22nd Century Group, Inc
Via GlobeNewswire
News headline image
22nd Century Group (Nasdaq: XXII) to Participate in March 2023 Roth Investor Conference
From 22nd Century Group, Inc
Via GlobeNewswire
News headline image
Marijuana Stock Movers For March 1, 2023 ↗
 
Via Benzinga
News headline image
22nd Century Group (Nasdaq: XXII) to Announce Fourth Quarter and Full Year 2022 Results on March 9, 2023
From 22nd Century Group, Inc
Via GlobeNewswire
News headline image
22nd Century Group (XXII) Accelerates Major Growing Program to Enable Implementation of New Zealand’s Reduced-Nicotine Content Tobacco Law
From 22nd Century Group, Inc
Via GlobeNewswire
News headline image
Bearish Sentiment Across The Cannabis Space - Check Full Movers For February 21, 2023 ↗
 
Via Benzinga
News headline image
Cannabis Stock Movers For February 15, 2023 ↗
 
Via Benzinga
News headline image
Bearish Wednesday For Marijuana Stocks - MedMen Enterprises, HEXO Among Top Gainers ↗
 
Via Benzinga
News headline image
Nearly Three Out of Four Colorado Smokers Want to Quit and Now Have a New Option That “Helps You Smoke Less”
From 22nd Century Group, Inc
Via GlobeNewswire
News headline image
Bullish Tuesday For Marijuana Stocks - iAnthus Capital Hldgs, TerrAscend Among Top Gainers ↗
 
Via Benzinga
News headline image
Cannabis Stock Movers For January 30, 2023 ↗
 
Via Benzinga
News headline image
Cannabis Stock Gainers And Losers From January 27, 2023 ↗
 
Via Benzinga
News headline image
22nd Century Group Acquires RX Pharmatech, Files U.S. Drug Master File For CBD API, Teams Up With Transo-Pharm ↗
22nd Century Group, Inc. (NASDAQ: XXII) announced the acquisition of privately held RX Pharmatech Ltd, a United Kingdom distributor of cannabinoids with 1,276 novel food applications with the U.K. Food... 
Via Benzinga
News headline image
22nd Century Group (XXII) Acquires RX Pharmatech Ltd, Greatly Strengthening UK and EU Market Position
From 22nd Century Group, Inc
Via GlobeNewswire
Marijuana Stock Movers For January 23, 2023 ↗
 
Via Benzinga
News headline image
22nd Century Group (XXII) Announces Filing of U.S. DMF (Drug Master File) for CBD API; New Global Sales, Marketing and Distribution Agreement with Transo-Pharm for Cannabinoid APIs
Partnership Will Provide Pharmaceutical Grade Cannabinoid Active Ingredients to the Largest Pharmaceutical and Consumer Goods Names in the Industry 
From 22nd Century Group, Inc
Via GlobeNewswire
News headline image
Marijuana Stock Movers For January 20, 2023 ↗
 
Via Benzinga
Cannabis Stock Gainers And Losers From January 19, 2023 ↗
 
Via Benzinga
Bullish Tuesday For Marijuana Stocks - MedMen Enterprises, Leef Brands Among Top Gainers ↗
 
Via Benzinga
Cannabis Stock Movers For January 16, 2023 ↗
 
Via Benzinga
Marijuana Stock Movers For January 13, 2023 ↗
 
Via Benzinga
Cannabis Stock Gainers And Losers From January 12, 2023 ↗
 
Via Benzinga
Cannabis Stock Gainers And Losers From January 5, 2023 ↗
 
Via Benzinga
< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
25 26 Next >